Nobiletin protected against hypertrophic cardiomyopathy via targeting PPARα

The nuclear receptor PPARα might be the potential endogenous receptor of the active ingredients of <i>C. reticulata</i>.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-08-04
DOI
https://doi.org/10.3389/fphar.2025.1628625
Citations
2
Primary Topic
Nuclear Receptors and Signaling
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nobiletin protected against hypertrophic cardiomyopathy via targeting PPARα

Kun Zhou, Panxia Wang, Xiaoqian Wu, Hui Cai et al.
2 citations
Frontiers in Pharmacology
Nuclear Receptors and Signaling
1.82
article

Nobiletin protected against hypertrophic cardiomyopathy via targeting PPARα

Kun Zhou, Panxia Wang, Xiaoqian Wu, Hui Cai, Q. Li, Cancan Wang, Luping Wang, Chen Chang, Zhujun Lian
article en
2 citations

Abstract

The nuclear receptor PPARα might be the potential endogenous receptor of the active ingredients of <i>C. reticulata</i>.

Frontiers in PharmacologyVol. 16
State Key Laboratory of Respiratory Disease (CN), Guangzhou Medical University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province
Good health and well-being
Openalex Percentile: Top 14%
Nuclear Receptors and Signaling
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.